In 1904, a physician wrote about a patient with leukemia who went into remission when he got the flu. Though the patient was not cured, it was a ray of hope at a time when there were no treatments for leukemia. Other cases were reported throughout the years of people with Burkitt’s Lymphoma and Hodgkin’s Lymphoma going into remission when they...
Read MoreIn a nutshell This study compared the effects of stem cell transplant to other newer treatments for recently diagnosed multiple myeloma (MM). The main finding was patients who received stem cell transplant had better outcomes than those who did not. Some background Stem cell transplant involves the transfer of cells to a patient. This is an effective...
Read MoreIn a nutshell This article investigated the long-term safety and effectiveness of tandem autologous/allogeneic hematopoietic cell transplantation (auto/alloHCT) for patients with multiple myeloma (MM). The authors concluded that this therapy is safe and can improve the overall survival of these patients. Some background...
Read MoreIn a nutshell This study monitored the development of minimal residual disease (MRD) after transplant for multiple myeloma (MM). The main finding was that different patterns of MRD development are associated with varying success after stem cell transplant for MM. Some background There are many treatments for MM. Patients are often cured fully by...
Read More
During July and early August of 2018, the Harris Poll in association with the American Society of Clinical Oncologists (ASCO’s) conducted a poll of 4,887 U.S. adults, 1001 of these have or had cancer. This second annual National Cancer Opinion Survey explored a wide range of topics. The findings clearly describe disparities in the care patients with...
Read MoreIn a nutshell This article investigated the safety and effectiveness of pomalidomide (Pomalyst) for the treatment of relapsed or refractory (does not respond to treatment) multiple myeloma (RRMM) in a real-life setting. The authors concluded that this treatment is safe and effective in these patients. Some background Multiple myeloma...
Read MoreIn a nutshell This study investigated the effect of kidney problems on the success of stem-cell transplant for Multiple Myeloma (MM). The main finding was that the stage of the kidney problems did not impact the effects of stem-cell transplant. Some background Stem-cell transplant involves the transfer of cells to a patient. It is commonly used in the...
Read MoreIn a nutshell This article investigated the safety and effectiveness of ixazomib (Ninlaro), melphalan (Alkeran), and prednisone (Deltasone) followed by maintenance (treatment meant to keep cancer from coming back) ixazomib for patients with multiple myeloma. The authors concluded that this...
Read MoreIn a nutshell This article investigated the safety and effectiveness of combining ixazomib (Ninlaro), cyclophosphamide (Cytoxan) and dexamethasone (Decadron) for the treatment of relapsed or refractory (does not respond to treatment) multiple myeloma (RRMM). The authors concluded that the combination treatment is safe and gave...
Read MoreIn a nutshell This article investigated the safety and effectiveness of adding daratumumab (Darzalex) to lenalidomide (Revlimid) and dexamethasone (Decadron) for the treatment of relapsed or refractory (does not respond to treatment) multiple myeloma (RRMM). The authors concluded that the addition of daratumumab is safe and...
Read MoreIn a nutshell This article investigated the safety and effectiveness of subcutaneous (under the skin) injection at home of bortezomib (Velcade) in elderly and frail patients on the bortezomib–melphalan–prednisone (VMP) regimen. The authors concluded that domestic injection of bortezomib is safe and can...
Read MoreIn a nutshell This article investigated the safety and effectiveness of high-dose therapy with autologous stem cell transplantation (HDT-ASCT) and maintenance treatment (treatment meant to keep cancer from coming back) with lenalidomide (Revlimid) for patients with multiple myeloma. The authors concluded that this therapy is safe...
Read More
